The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Lina
The Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based implementation of the Unity MR-Linac technology and further technical development of the MR-Linac system with the ultimate purpose to improve patients
| Condition(s) | Oncology, Breast Cancer, Prostate Cancer, Gynecologic Cancer, Brain Tumor, Brain Cancer, Gynecologic Tumor, Prostate Tumor, Prostate Neoplasm, Breast Tumor, Radiation Toxicity, Quality of Life, Rectal |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based implementation of the Unity MR-Linac technology and further technical development of the MR-Linac system with the ultimate purpose to improve patients' survival, local, and regional tumor control and quality of life. |
| Who can participate | Inclusion Criteria: * Patient is to undergo or has completed imaging or treatment procedures on an MR-Linac; * Patient provides written, informed consent; * Patient is 18 years old or older. Exclusion Criteria: * MRI exclusion criteria, including * MRI contraindications as per usual clinical care, such as (possible) pregnancy; claustrophobia and metal or electronic implants not compatible with MRI. |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | UMC Utrecht |
| Locations | Pittsburgh, Pennsylvania, United States; Houston, Texas, United States; Milwaukee, Wisconsin, United States; Melbourne, Australia; Brussels, Belgium; Toronto, Ontario, Canada (+12 more sites) |
| Start date | 2019-02-01 |
| NCT ID | NCT04075305 |
| Official listing | https://clinicaltrials.gov/study/NCT04075305 |